| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 1.146 | 5.570 | 10.708 | 10.360 | 11.924 | 16.791 | 23.899 | 23.559 |
| Total Income - EUR | - | - | 1.146 | 5.570 | 10.708 | 12.361 | 11.924 | 16.791 | 23.902 | 41.049 |
| Total Expenses - EUR | - | - | 216 | 1.957 | 4.455 | 4.108 | 4.172 | 8.451 | 10.752 | 31.531 |
| Gross Profit/Loss - EUR | - | - | 930 | 3.613 | 6.252 | 8.253 | 7.752 | 8.340 | 13.150 | 9.518 |
| Net Profit/Loss - EUR | - | - | 896 | 3.445 | 5.931 | 7.954 | 7.437 | 7.846 | 10.562 | 7.315 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Medpath Lab Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 1.124 | 868 | 668 | 936 | 966 | 19.542 | 39.308 |
| Current Assets | - | - | 1.081 | 3.295 | 9.882 | 11.318 | 17.766 | 19.378 | 16.711 | 13.564 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 223 | 0 | 388 | 660 | 2.196 | 3.244 | 162 |
| Cash | - | - | 1.081 | 3.072 | 9.882 | 10.930 | 17.106 | 17.182 | 13.468 | 13.402 |
| Shareholders Funds | - | - | 940 | 4.368 | 10.214 | 11.445 | 18.629 | 20.129 | 30.630 | 37.774 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 141 | 52 | 537 | 541 | 74 | 215 | 5.624 | 15.098 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Medpath Lab Srl